OP0284 Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA: data from the avert trial

H Ahmad; J Baker; M Østergaard; P Emery; P Durez; J Ye; S Banerjee; P Conaghan

doi:10.1136/annrheumdis-2017-eular.1723

OP0284 Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA: data from the avert trial

H Ahmad, J Baker, M Østergaard, P Emery, P Durez, J Ye, S Banerjee, P Conaghan

Department of Clinical Medicine

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	76
Issue number	Suppl 2
Pages (from-to)	174
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2017-eular.1723
Publication status	Published - 2017

Access to Document

10.1136/annrheumdis-2017-eular.1723

174.1.full.pdfFinal published version, 69.9 KB

Cite this

Ahmad, H., Baker, J., Østergaard, M., Emery, P., Durez, P., Ye, J., Banerjee, S., & Conaghan, P. (2017). OP0284 Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA: data from the avert trial. Annals of the Rheumatic Diseases, 76(Suppl 2), 174. https://doi.org/10.1136/annrheumdis-2017-eular.1723

OP0284 Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA : data from the avert trial. / Ahmad, H; Baker, J; Østergaard, M et al.

In: Annals of the Rheumatic Diseases, Vol. 76, No. Suppl 2, 2017, p. 174.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Ahmad, H, Baker, J, Østergaard, M, Emery, P, Durez, P, Ye, J, Banerjee, S & Conaghan, P 2017, 'OP0284 Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA: data from the avert trial', Annals of the Rheumatic Diseases, vol. 76, no. Suppl 2, pp. 174. https://doi.org/10.1136/annrheumdis-2017-eular.1723

@article{537248b98b4a4852ac3ac5d8d48862bb,

title = "OP0284 Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NA{\"I}VE RA: data from the avert trial",

author = "H Ahmad and J Baker and M {\O}stergaard and P Emery and P Durez and J Ye and S Banerjee and P Conaghan",

year = "2017",

doi = "10.1136/annrheumdis-2017-eular.1723",

language = "English",

volume = "76",

pages = "174",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - OP0284 Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA

T2 - data from the avert trial

AU - Ahmad, H

AU - Baker, J

AU - Østergaard, M

AU - Emery, P

AU - Durez, P

AU - Ye, J

AU - Banerjee, S

AU - Conaghan, P

PY - 2017

Y1 - 2017

U2 - 10.1136/annrheumdis-2017-eular.1723

DO - 10.1136/annrheumdis-2017-eular.1723

M3 - Conference abstract in journal

SN - 0003-4967

VL - 76

SP - 174

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

ER -